Growth and Recent Launch Hycor Biomedical recently launched NOVEOS, a fully automated allergy testing system, signaling a growth phase and potential upsell opportunities from HYTEC and AUTOSTAT product users seeking advanced sIgE testing with lower sample requirements and reduced interference.

Allergy Market Focus Specialization in in vitro allergy diagnostics positions Hycor to target clinical laboratories, hospitals and doctors’ offices expanding or upgrading allergy testing capabilities; consider partnerships or distributed sales through labs expanding allergy programs.

Global Expansion Readiness As a global manufacturer with a long-standing allergy testing portfolio, there is potential to scale through international distributors or direct global partnerships to accelerate NOVEOS adoption in regional markets with strong demand for automated sIgE solutions.

Mid-market Revenue Potential Current revenue range and funding indicate a mid-sized company with room for strategic deals, bundled offerings, and service contracts that pair NOVEOS implementation with HYTEC and AUTOSTAT support to increase average deal size.

Technology and Engagement Leveraging existing tech stack and digital channels (Salesforce Marketing Cloud, Open Graph, WordPress, Google tools) presents an opportunity for targeted lead nurturing, product webinars, and case studies to drive awareness and accelerate trials with key decision makers.